Mediastinal Masses:
Journal
Seminars in nuclear medicine
ISSN: 1558-4623
Titre abrégé: Semin Nucl Med
Pays: United States
ID NLM: 1264464
Informations de publication
Date de publication:
01 2021
01 2021
Historique:
entrez:
28
11
2020
pubmed:
29
11
2020
medline:
1
12
2021
Statut:
ppublish
Résumé
Imaging plays a key role in the management of mediastinal masses. In an effort to standardize the analysis of the mediastinum, the International Thymic Malignancy Interest Group (ITMIG) has proposed a three compartments-based diagnostic classification, intended for clinicians and radiologists. Several articles have documented its usefulness to guide the diagnosis using cross-sectional imaging. Similarly, fluorine-18-radiolabeled fluorodeoxyglucose positron emission tomography combined to computed tomography (
Identifiants
pubmed: 33246542
pii: S0001-2998(20)30078-7
doi: 10.1053/j.semnuclmed.2020.07.007
pii:
doi:
Substances chimiques
Fluorine Radioisotopes
0
Radiopharmaceuticals
0
Fluorodeoxyglucose F18
0Z5B2CJX4D
Fluorine-18
GZ5I74KB8G
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
79-97Informations de copyright
Copyright © 2020 Elsevier Inc. All rights reserved.